What is SiPhox?
SiPhox Health provides comprehensive at-home health testing, analyzing over 50 vital blood markers with clinically accurate results delivered within 3-5 working days. Their FSA and HSA-approved programs empower individuals to proactively manage their health by preventing serious issues, optimizing lifestyle choices, and tracking progress from home. This approach addresses a growing demand for accessible and personalized health monitoring solutions.
How much funding has SiPhox raised?
SiPhox has raised a total of $681K across 1 funding round:
Grant
$681K
Grant (2022): $681K with participation from Massachusetts Manufacturing Innovation Initiative
Key Investors in SiPhox
Massachusetts Manufacturing Innovation Initiative
The Massachusetts Manufacturing Innovation Initiative is a state-backed program focused on fostering innovation and advanced manufacturing within the region, likely supporting companies with significant technological and industrial impact.
What's next for SiPhox?
The recent major strategic investment signals a pivotal growth phase for SiPhox. This capital infusion is expected to fuel advancements in their testing technology, expand their service offerings, and enhance their market reach. The company is poised to further solidify its position as a leader in the burgeoning at-home diagnostics market, leveraging this financing to drive innovation and scale operations.
See full SiPhox company page
